Agios Pharmaceuticals reported $70K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amgen AMGN:US $ 31877M 71M
Arrowhead Research ARWR:US $ 197K 1000
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 328M 0M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Epizyme EPZM:US $ 0.01M 0M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 1M
Immunogen IMGN:US $ 2M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Moderna Inc MRNA:US 0 0
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 913M 0M
Novartis NVS:US $ 913M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
YTE INCY:US $ 0.22M 0M